Education
About Us
Working with TipRanks
Follow Us
Semler Scientific (SMLR)
NASDAQ:SMLR
SMLR Stock Chart & Stats
$27.42
-$4.62(-8.36%)
At close: 4:00 PM EST
$27.42
-$4.62(-8.36%)
Day’s Range― - ―
52-Week Range$21.84 - $81.56
Previous CloseN/A
Volume122.03K
Average Volume (3M)1.14M
Market Cap
$469.25M
Enterprise Value$508.54M
Total Cash (Recent Filing)$13.48M
Total Debt (Recent Filing)$96.28M
Price to Earnings (P/E)11.8
Beta1.84
Next Earnings
Mar 10, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding19,593,096
10 Day Avg. Volume1,083,606
30 Day Avg. Volume1,141,590
Financial Highlights & Ratios
PEG Ratio0.11
Price to Book (P/B)1.69
Price to Sales (P/S)6.93
P/FCF Ratio16.03
Enterprise Value/Market Cap1.08
Enterprise Value/Revenue11.83
Enterprise Value/Gross Profit13.03
Enterprise Value/Ebitda-22.22
Forecast
1Y Price Target
$83.00Price Target Upside202.70% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Acquisition PremiumStrive's agreement to acquire Semler Scientific represents a significant value to shareholders with a 123% premium over the current trading price.
Bitcoin StrategySemler Scientific has announced a strategy to accumulate Bitcoin, aiming to hold 10,000 BTC by the end of 2025 and 105,000 BTC by the end of 2027, which might enhance its market value.
Market ExpansionSMLR announced that it formed CardioVanta, a wholly owned subsidiary, to focus on new assets in the cardiovascular market, potentially increasing the total addressable market.
Bears Say
Customer Usage ReductionA major customer significantly reduces its usage of QuantaFlo, impacting revenue.
Reimbursement ChallengesThere is an expected decline in revenue due to the new Medicare Advantage risk adjustment model and lower reimbursement rates, impacting the financial outlook in the short term.
Revenue DeclineThe medical device business is experiencing declining revenue, which is related to reimbursement cuts, not product issues.
Semler Scientific News
SMLR FAQ
What was Semler Scientific’s price range in the past 12 months?
Semler Scientific lowest stock price was $21.84 and its highest was $81.56 in the past 12 months.
What is Semler Scientific’s market cap?
Semler Scientific’s market cap is $469.25M.
When is Semler Scientific’s upcoming earnings report date?
Semler Scientific’s upcoming earnings report date is Mar 10, 2026 which is in 122 days.
How were Semler Scientific’s earnings last quarter?
Currently, no data Available
Is Semler Scientific overvalued?
According to Wall Street analysts Semler Scientific’s price is currently Undervalued.
Does Semler Scientific pay dividends?
Semler Scientific does not currently pay dividends.
What is Semler Scientific’s EPS estimate?
Semler Scientific’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Semler Scientific have?
Semler Scientific has 19,593,096 shares outstanding.
What happened to Semler Scientific’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Semler Scientific?
Currently, no hedge funds are holding shares in SMLR
Semler Scientific Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$83.00 (202.70% Upside)
$83.00 (202.70% Upside)
Blogger Sentiment
Bullish
SMLR Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 190.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▲ 0.5%
Last 30 Days ▲ 1.7%
Last 30 Days ▲ 1.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-26.30%
12-Months-Change
Fundamentals
Return on Equity
16.04%
Trailing 12-Months
Asset Growth
516.37%
Trailing 12-Months
Company Description
Semler Scientific
Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.
SMLR Company Deck
SMLR Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant achievements in Bitcoin accumulation and financial performance, although the decline in healthcare revenues and operating losses presented challenges. The company's strategic initiatives in Bitcoin and healthcare expansion suggest optimism for future growth.View all SMLR earnings summariesSMLR Stock 12 Month Forecast
Average Price Target
$83.00
▲(202.70% Upside)
Technical Analysis
Ownership Overview
9.19% Insiders
10.23% Mutual Funds
0.16% Other Institutional Investors
72.67% Public Companies and Individual Investors